Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Thin Film Drug Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

Table of Content

1. Preface 
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology 

3. Executive Summary

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity 
     4.5. Global Thin Film Drug Manufacturing  Analysis and Forecasts, 2016–2024
     4.6. Thin Film Drug Manufacturing  - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Value Chain Analysis
     4.9. Market Outlook

5.  Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Product
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Product, 2016–2024
            5.4.1. Oral Thin Film
                     5.4.1.1. Sublingual film
                     5.4.1.2. Fully dissolving dental/ buccal film
            5.4.2. Transdermal Thin Film
            5.4.3. Others
     5.5. Product  Comparison Matrix
     5.6. Market Attractiveness By Product
     5.7. Oral Thin Film Drugs : Key market insights
            5.7.1. Pipeline Analysis
            5.7.2. Technology Insights
            5.7.3. Key Product Insights

6. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Distribution Channel
     6.1. Introduction & Definition
     6.2. Key Findings
     6.3. Market Value Forecast By Distribution Channel, 2016–2024
            6.3.1. Hospital Pharmacies
            6.3.2.  Drug Stores
            6.3.3. Retail Pharmacies
            6.3.4. E- Commerce
     6.4. Distribution Channel  Comparison Matrix
     6.5. Market Attractiveness By Distribution Channel 

7. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Disease Indication
     7.1. Introduction & Definition
     7.2. Key Findings
     7.3. Key Trends
     7.4. Market Value Forecast By Disease Indication, 2016–2024
            7.4.1. Schizophrenia
            7.4.2. Migraine
            7.4.3. Opioid Dependence
            7.4.4. Nausea & Vomiting
            7.4.5. Others
     7.5. Disease Indication Comparison Matrix
     7.6. Market Attractiveness By Disease Indication

8. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Region
     8.1. Introduction & Definition
     8.2. Key Findings
     8.3. Market Value Forecast By Region
            8.3.1. North America
            8.3.2. Latin America 
            8.3.3. Asia Pacific
            8.3.4. Europe
            8.3.5. Middle East & Africa
     8.4. Market Attractiveness By Country/Region

9. North America Thin Film Drug Manufacturing  Analysis and Forecast
     9.1. Introduction
     9.2. Market Value Forecast By Product, 2016–2024
            9.2.1. Oral Thin Film
                     9.2.1.1. Sublingual film
                     9.2.1.2. Fully dissolving dental/ buccal film
            9.2.2. Transdermal Thin Film
            9.2.3. Others (Ocular Thin Film, etc.)
     9.3. Market Value Forecast By Distribution Channel, 2016–2024
            9.3.1. Hospital Pharmacies
            9.3.2. Drug Stores
            9.3.3. Retail Pharmacies
            9.3.4. E- Commerce
     9.4. Market Value Forecast By Disease Indication, 2016–2024
            9.4.1. Schizophrenia
            9.4.2. Migraine
            9.4.3. Opioid Dependence
            9.4.4. Nausea & Vomiting
            9.4.5. Others
     9.5. Market Value Forecast By Country, 2016–2024
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Product
            9.6.2. By Distribution Channel
            9.6.3. By Disease Indication
            9.6.4. By Country

10. Latin America Thin Film Drug Manufacturing  Analysis and Forecast
     10.1. Introduction
     10.2. Market Value Forecast By Product, 2016–2024
            10.2.1. Oral Thin Film
                     10.2.1.1. Sublingual film
                     10.2.1.2. Fully dissolving dental/ buccal film
            10.2.2. Transdermal Thin Film
            10.2.3. Others (Ocular Thin Film, etc.)
     10.3. Market Value Forecast By Distribution Channel, 2016–2024
            10.3.1. Hospital Pharmacies
            10.3.2. Drug Stores
            10.3.3. Retail Pharmacies
            10.3.4. E- Commerce
     10.4. Market Value Forecast By Disease Indication, 2016–2024
            10.4.1. Schizophrenia
            10.4.2. Migraine
            10.4.3. Opioid Dependence
            10.4.4. Nausea & Vomiting
            10.4.5. Others
     10.5. Market Value Forecast By Country, 2016–2024
            10.5.1. Brazil
            10.5.2. Mexico
            10.5.3. Rest of Latin America
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product
            10.6.2. By Distribution Channel
            10.6.3. By Disease Indication
            10.6.4. By Country

11. Asia Pacific Thin Film Drug Manufacturing  Analysis and Forecast
     11.1. Introduction
     11.2. Market Value Forecast By Product, 2016–2024
            11.2.1. Oral Thin Film
                     11.2.1.1. Sublingual film
                     11.2.1.2. Fully dissolving dental/ buccal film
            11.2.2. Transdermal Thin Film
            11.2.3. Others (Ocular Thin Film, etc.)
     11.3. Market Value Forecast By Distribution Channel, 2016–2024
            11.3.1. Hospital Pharmacies
            11.3.2. Drug Stores
            11.3.3. Retail Pharmacies
            11.3.4. E- Commerce
     11.4. Market Value Forecast By Disease Indication, 2016–2024
            11.4.1. Schizophrenia
            11.4.2. Migraine
            11.4.3. Opioid Dependence
            11.4.4. Nausea & Vomiting
            11.4.5. Others
     11.5. Market Value Forecast By Country, 2016–2024
            11.5.1. Japan
            11.5.2. India
            11.5.3. China
            11.5.4. Rest Of Asia Pacific
     11.6. Market Attractiveness Analysis 
            11.6.1. By Product
            11.6.2. By Distribution Channel
            11.6.3. By Disease Indication
            11.6.4. By Country

12.  Europe Thin Film Drug Manufacturing  Analysis and Forecast
     12.1. Introduction
     12.2. Market Value Forecast By Product, 2016–2024
            12.2.1. Oral Thin Film
                     12.2.1.1. Sublingual film
                     12.2.1.2. Fully dissolving dental/ buccal film
            12.2.2. Transdermal Thin Film
            12.2.3. Others (Ocular Thin Film, etc.)
     12.3. Market Value Forecast By Distribution Channel, 2016–2024
            12.3.1. Hospital Pharmacies
            12.3.2. Drug Stores
            12.3.3. Retail Pharmacies
            12.3.4. E- Commerce
     12.4. Market Value Forecast By Disease Indication, 2016–2024
            12.4.1. Schizophrenia
            12.4.2. Migraine
            12.4.3. Opioid Dependence
            12.4.4. Nausea & Vomiting
            12.4.5. Others
     12.5. Market Value Forecast By Country, 2016–2024
            12.5.1. France
            12.5.2. Germany 
            12.5.3. Italy
            12.5.4. Spain
            12.5.5. Russia
            12.5.6. Rest Of Europe
     12.6. Market Attractiveness Analysis 
            12.6.1. By Product
            12.6.2. By Distribution Channel
            12.6.3. By Disease Indication
            12.6.4. By Country

13. Middle East & Africa Thin Film Drug Manufacturing  Analysis and Forecast
     13.1.  Introduction
     13.2. Market Value Forecast By Product, 2016–2024
            13.2.1. Oral Thin Film
                     13.2.1.1. Sublingual film
                     13.2.1.2. Fully dissolving dental/ buccal film
            13.2.2. Transdermal Thin Film
            13.2.3. Others (Ocular Thin Film, etc.)
     13.3. Market Value Forecast By Distribution Channel, 2016–2024
            13.3.1. Hospital Pharmacies
            13.3.2. Drug Stores
            13.3.3. Retail Pharmacies
            13.3.4. E- Commerce
     13.4. Market Value Forecast By Disease Indication, 2016–2024
            13.4.1. Schizophrenia
            13.4.2. Migraine
            13.4.3. Opioid Dependence
            13.4.4. Nausea & Vomiting
            13.4.5. Others
     13.5. Market Value Forecast By Country, 2016–2024
            13.5.1. South Africa
            13.5.2. Saudi Arabia
            13.5.3. UAE
            13.5.4. Rest of Middle East & Africa
     13.6. Market Attractiveness Analysis 
            13.6.1. By Product
            13.6.2. By Distribution Channel
            13.6.3. By Disease Indication
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.2.1. ZIM Laboratories Limited
                     14.2.1.1. Company Details
                     14.2.1.2. Business Overview
                     14.2.1.3. Financial Overview
                     14.2.1.4. Strategic Overview
                     14.2.1.5. SWOT Analysis
            14.2.2. Indivior plc.
                     14.2.2.1. Company Details
                     14.2.2.2. Business Overview
                     14.2.2.3. Financial Overview
                     14.2.2.4. Strategic Overview
                     14.2.2.5. SWOT Analysis
            14.2.3. MonoSol Rx Allergan plc.
                     14.2.3.1. Company Details
                     14.2.3.2. Business Overview
                     14.2.3.3. Financial Overview
                     14.2.3.4. Strategic Overview
                     14.2.3.5. SWOT Analysis
            14.2.4. Sumitomo Dainippon Pharma Co., Ltd.
                     14.2.4.1. Company Details
                     14.2.4.2. Business Overview
                     14.2.4.3. Financial Overview
                     14.2.4.4. Strategic Overview
                     14.2.4.5. SWOT Analysis
            14.2.5. IntelGenx Corp
                     14.2.5.1. Company Details
                     14.2.5.2. Business Overview
                     14.2.5.3. Financial Overview
                     14.2.5.4. Strategic Overview
                     14.2.5.5. SWOT Analysis
            14.2.6. Pfizer, Inc.
                     14.2.6.1. Company Details
                     14.2.6.2. Business Overview
                     14.2.6.3. Financial Overview
                     14.2.6.4. Strategic Overview
                     14.2.6.5. SWOT Analysis
            14.2.7. Novartis AG
                     14.2.7.1. Company Details
                     14.2.7.2. Business Overview
                     14.2.7.3. Financial Overview
                     14.2.7.4. Strategic Overview
                     14.2.7.5. SWOT Analysis
            14.2.8. Allergan plc.
                     14.2.8.1. Company Details
                     14.2.8.2. Business Overview
                     14.2.8.3. Financial Overview
                     14.2.8.4. Strategic Overview
                     14.2.8.5. SWOT Analysis
            14.2.9. NAL Pharma
                     14.2.9.1. Company Details
                     14.2.9.2. Business Overview
                     14.2.9.3. Financial Overview
                     14.2.9.4. Strategic Overview
                     14.2.9.5. SWOT Analysis
            14.2.10. Wolters Kluwer
                     14.2.10.1. Company Details
                     14.2.10.2. Business Overview
                     14.2.10.3. Financial Overview
                     14.2.10.4. Strategic Overview
                     14.2.10.5. SWOT Analysis
            14.2.11. Solvay
                     14.2.11.1. Company Details
                     14.2.11.2. Business Overview
                     14.2.11.3. Financial Overview
                     14.2.11.4. Strategic Overview
                     14.2.11.5. SWOT Analysis

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote